Pretest - Tumor Board Tuesday - May 4, 2021 (ID: i788-9)

Question Title

* 1. Please list your last name and zip code:

Last name:

ZIP/Postal Code:

Question Title

* 2. What is your specialty?

Question Title

* 3. How many patients with cholangiocarcinoma do you treat each week?

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 4. What major electrolyte abnormalities are associated with FGFR inhibitors?

Hypokalemia

Hyperphosphatemia

Hypophosphatemia

Hypocalcemia

Question Title

* 5. When should NGS be performed in metastatic/unresectable cholangiocarcinoma?

At diagnosis

After progression on first-line therapy

No role for NGS